Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correspondence between the CYP2C19 and CYP3A4 genotypes with the inferred metabolizer phenotype by omeprazole administration in Mexican healthy children.

Journal of clinical pharmacy and therapeutics - 1 Oct 2018

Favela-Mendoza A F, Martínez-Cortes G, Romero-Prado M M, Romero-Tejeda E M, Islas-Carbajal M C, Sosa-Macias M, Lares-Asseff I, Rangel-Villalobos H

Abstract excerpt

WHAT IS KNOWN AND OBJECTIVE: CYP2C19 genotypes presumably allow the prediction of the metabolizer phenotypes: poor (PMs), extensive (EMs) and ultra-rapid (UMs). However, evidence from previous studies regarding this predictive power is unclear, which is important because the benefits expected by healthcare institutions and patients are based on this premise. Therefore, we aimed to complete a formal evaluation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Ulcer Agents
Share to Child

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Cytochrome P-450 CYP3A

Share to Hydroxylation

Share to Mexico

Share to Omeprazole

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 29733119
DOI: 10.1111/jcpt.12699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correspondence between the CYP2C19 and CYP3A4 genotypes with the inferred metabolizer phenotype by omeprazole administration in Mexican healthy children.PMID 29733119Read ↗

CYP2C19- and CYP3A4-dependent omeprazole metabolism in West Mexicans.Semantic proximity Read ↗

Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction.Semantic proximity Read ↗

Genetic variability of CYP2C19 in a Mexican population: contribution to the knowledge of the inheritance pattern of CYP2C19*17 to develop the ultrarapid metabolizer phenotype.Semantic proximity Read ↗

CYP2C19 genotype-phenotype correlation: current insights and unanswered questionsSemantic proximity Read ↗

Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19.Semantic proximity Read ↗

Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Semantic proximity Read ↗

Phenoconversion Due to Drug-Drug Interactions in CYP2C19 Genotyped Healthy Volunteers.Semantic proximity Read ↗

The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.Semantic proximity Read ↗

Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.Semantic proximity Read ↗

The impact of CYP2C19 genotype on phenoconversion by concomitant medicationSemantic proximity Read ↗

Distribution of CYP2C19 polymorphism and predicted metabolizer phenotypes in the Indian population: A systematic review.Semantic proximity Read ↗

CYP2C19 genotype and phenotype determined by omeprazole in a Korean population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.